Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
sell

Intercept Pharmaceuticals sell BiotechBee

Intercept Pharmaceuticals
Start price
€13.70
30.09.22 / 40%
Target price
€9.00
31.01.23
Performance (%)
-12.08%
End price
€12.05
03.01.23
Summary
This prediction ended on 03.01.23 with a price of €12.05. The prediction for Intercept Pharmaceuticals closed with a convincing performance of -12.08%. BiotechBee has 40% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Intercept Pharmaceuticals - - -
iShares Core DAX® 2.594% -1.158% 14.782%
iShares Nasdaq 100 3.553% -1.727% 43.265%
iShares Nikkei 225® 0.687% -8.354% 18.454%
iShares S&P 500 2.209% -0.942% 31.361%

According to BiotechBee what are the pros and cons of Intercept Pharmaceuticals for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Cons

Comments by BiotechBee for this prediction

In the thread Intercept Pharmaceuticals diskutieren
Prediction Sell
Perf. (%) -12.08%
Target price 10.000
Change
Ends at 31.01.23

Sell mit Kursziel 10,0

BiotechBee 
0
Report Share
30.09.22
Prediction Sell
Perf. (%) -12.08%
Target price 9.000
Change
Ends at 31.01.23

Kursziel geändert auf 9,0

BiotechBee 
0
Report Share
30.09.22
In the thread Trading Intercept Pharmaceuticals
Prediction Buy
Perf. (%) -12.08%
Target price 9.000
Change
Ends at 31.01.23

Sell beendet

BiotechBee 
0
Report Share
03.01.23

Stopped prediction by BiotechBee for Intercept Pharmaceuticals

buy
Intercept Pharmaceuticals

Start price
Target price
Perf. (%)
€16.65
20.09.22
€32.00
31.01.23
-17.72%
30.09.22

Could be very worthwhile Investment >20% year
BiotechBee 
20.09.22 40%